Timothy Watkins, MD, MSc, Vice President, Clinical Development of Inflammation Therapeutics, Gilead Sciences
Advertisement
Articles by Timothy Watkins, MD, MSc, Vice President, Clinical Development of Inflammation Therapeutics, Gilead Sciences
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Treatment Selection, Adherence, and Misconceptions in Pediatric Atopic Dermatitis
2
New Topicals in Atopic Dermatitis: Evidence, Barriers, and Real-World Perspectives
3
Atacicept and Upstream Immune Targeting in IgAN With Richard Lafayette, MD
4
Enlicitide’s FDA Approval for LDL-C Reduction and the CORALreef Outcomes Trial
5